BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both companies in several countries, including […]

ALAMEDA, Calif. and PRINCETON, N.J. — CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic collaboration to generate pilot data on the CellFE High Volume Cyva™ System. This partnership will validate the clinical-scale performance of CellFE’s innovative, non-viral gene editing microfluidics technology for both activated […]

New assay delivers high-resolution whole transcriptome data to explore biology beyond known genes PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Visium HD 3’ Gene Expression, a powerful new assay that expands the capabilities of the Visium HD portfolio beyond the boundaries of known […]

ANN ARBOR, Mich. — Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announces the broad integration capability of its flagship product, microbubble-based cell separation. Microbubble integration into existing platforms enables scaled-up centralized and decentralized cell therapies, reducing footprint and cost. By leveraging microbubble technology, users gain a reduced footprint for cell therapy manufacturing, seamless integration, and healthier cells. Akadeum is […]

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world’s first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between May 13th – 17th at the New Orleans Ernest N. Morial Convention Center. Bio-Techne will feature its cutting-edge […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between May 13th – 17th at the New Orleans Ernest N. Morial Convention Center. Bio-Techne will feature its cutting-edge […]

The Federal Circuit rejects Bruker Cellular’s invalidity challenge to AbCellera’s patent for microfluidic devices and their use in culturing cells VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced that the United States Court of Appeals for the Federal Circuit (CAFC) has by a Rule 36 Order affirmed judgment of validity of its U.S. Patent […]

Vienna, Austria — Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a market-registered GMP-manufacturer of the nuclease. Biomay is the […]

CAMBRIDGE, UK – Lightcast Discovery Ltd., a pioneering life science tools company, today announced the limited commercial release of its Envisia™ benchtop platform — a breakthrough droplet-based, single-cell functional analysis system designed to accelerate antibody discovery and development. The company will debut the instrument at Booth #711 and present new data from its technology access program at the Essential […]